bioAffinity Technologies, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | 08/08/2025 | 125.46 K | $36.03 K | 5.70% | 0.77% |
| ALLWORTH FINANCIAL LP | 08/07/2025 | 53.73 K | $15.43 K | 100.00% | 0.33% |
| VANGUARD GROUP INC | 08/11/2025 | 40.64 K | $11.66 K | -77.03% | 0.25% |
| CAPTRUST FINANCIAL ADVISORS | 08/15/2025 | 27.89 K | $8.01 K | 0.00% | 0.17% |
| IFP ADVISORS, INC | 07/24/2025 | 25.00 K | $7.18 K | 66.67% | 0.15% |
| STATE STREET CORP | 08/14/2025 | 17.60 K | $5.06 K | 0.00% | 0.11% |
| XTX TOPCO LTD | 08/12/2025 | 15.60 K | $4.48 K | 23.72% | 0.10% |
| STONEX GROUP INC. | 08/13/2025 | 15.21 K | $4.37 K | 100.00% | 0.09% |
| NORTHERN TRUST CORP | 08/13/2025 | 13.66 K | $3.92 K | 0.00% | 0.08% |
| CREATIVE PLANNING | 08/08/2025 | 12.10 K | $3.47 K | 0.00% | 0.07% |
| SPROTT INC. | 08/11/2025 | 10.00 K | $2.87 K | 100.00% | 0.06% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 08/15/2025 | 3.13 K | $898 | -0.41% | 0.02% |
| CITIGROUP INC | 08/11/2025 | 1.48 K | $424 | 100.00% | 0.01% |
| RAYMOND JAMES FINANCIAL INC | 08/14/2025 | 500 | $144 | 100.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 08/14/2025 | 205 | $58 | 132.95% | 0.00% |
| MORGAN STANLEY | 08/15/2025 | 100 | $29 | -66.67% | 0.00% |
| UBS GROUP AG | 08/14/2025 | 24 | $7 | 100.00% | 0.00% |
| JPMORGAN CHASE & CO | 08/12/2025 | 0 | $0 | -100.00% | 0.00% |
| BARCLAYS PLC | 08/14/2025 | 0 | $0 | -100.00% | 0.00% |
| HRT FINANCIAL LP | 08/14/2025 | 0 | $0 | -100.00% | 0.00% |
| WARBERG ASSET MANAGEMENT LLC | 08/12/2025 | 0 | $0 | -100.00% | 0.00% |
| VAN HULZEN ASSET MANAGEMENT, LLC | 08/13/2025 | 0 | $0 | -100.00% | 0.00% |
bioAffinity Technologies, Inc. institutional Ownership - FAQ's
During the previous two years, 18 institutional investors and hedge funds held shares of bioAffinity Technologies, Inc.. The most heavily invested institutionals were:
IFP Advisors, Inc: 25,000
CITIGROUP INC: 0
Allworth Financial LP: 0
VANGUARD GROUP INC: 0
Creative Planning: 0
Tower Research Capital LLC (TRC): 0
2.23% of bioAffinity Technologies, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 78.73 K shares in the last 24 months. This purchase volume represents approximately $205.50 K in transactions.